Table 1—

Study subject characteristics

SubjectAge (years)SexDiabetes duration (years)BMI (kg/m2)A1C (%)Fasting insulin (pmol/l)
Control subjects (mean ± SD)30 ± 4.021.8 ± 1.052 ± 10.0
124M21.829
226F19.720
325M23.474
451F21.264
529M25.544
626F19.079
Placebo-treated subjects (mean ± SD)40.0 ± 2.02.5 ± 0.336.6 ± 1.37.0 ± 0.6206 ± 24.0
741F331.26.9190
833F336.76.4155
945F138.07.0280
1037M240.15.9269
1144M334.510.1140
1237M339.15.9199
Pioglitazone-treated subjects (mean ± SD)46 ± 5.03.7 ± 1.532.1 ± 2.27.3 ± 1.0166 ± 34.0
1347M125.55.9207
1455F637.18.0232
1553M234.07.2143
1624F1037.711.7266
1749F225.85.370
1845M132.45.677